An assessment of the developmental toxicity of inorganic arsenic
Tóm tắt
Từ khóa
Tài liệu tham khảo
Boyle, 1973, The geochemistry of arsenic and its use as an indicator element in geochemical prospecting, J Geochem Explor, 2, 251, 10.1016/0375-6742(73)90003-4
Tamaki, 1992, Environmental biochemistry of arsenic, Rev Environ Contam Toxicol, 124, 79
Waugh, 1982, Arsenic, 715
International Agency for Research on Cancer (IARC), World Health Organization. Arsenic and arsenic compounds. In: IARC monographs on the evaluation of carcinogenic risk of chemicals to man, vol. 23, Some metals and metallic compounds. Lyon: IARC; 1980:39–141.
Aposhian, 1989, Biochemical toxicology of arsenic, Rev Biochem Toxicol, 10, 265
Vallee, 1960, Arsenic toxicology and biochemistry, AMA Arch Industr Health, 21, 132
Klaassen, 1990, Heavy metals and heavy metal antagonists, 1592
Winship, 1984, Toxicity of inorganic arsenic salts, Adverse Drug React Acute Poisoning Rev, 3, 129
U. S. Department of Health and Human Services, Public Health Service. Arsenic and certain arsenic compounds. In: Fifth annual report on carcinogens: summary. NTP 89–239. Washington, DC: U. S. Government Printing Office; 1989:3–8.
Integrated Risk Information Service (IRIS), U. S. Environmental Protection Agency. IRIS substance file: arsenic, inorganic. Web page http://www.epa.gov/ngispgm3/iris/subst/0278.htm. March. 1997.
Shepard, 1995
Schardein, 1985
Barlow, 1982
Nisbet, 1983
Hemminki, 1985, Extrapolation of evidence on teratogenicity of chemicals between humans and experimental animals, Teratogen Carcinogen Mutagen, 5, 251, 10.1002/tcm.1770050405
Ferm, 1972, The teratogenic effects of metals on mammalian embryos, Adv Teratol, 5, 51
Léonard, 1980, Carcinogenicity, teratogenicity and mutagenicity of arsenic, Mutat Res, 75, 49, 10.1016/0165-1110(80)90027-5
Ferm, 1983, Metal-induced congenital malformations, 383
Domingo, 1994, Metal-induced developmental toxicity in mammals, J Toxicol Environ Health, 42, 123, 10.1080/15287399409531868
Golub, 1994, Maternal toxicity and the identification of inorganic arsenic as a developmental toxicant, Reprod Toxicol, 8, 283, 10.1016/0890-6238(94)90044-2
Shalat, 1996, Role of arsenic as a reproductive toxin with particular attention to neural tube defects, J Toxicol Environ Health, 48, 253, 10.1080/009841096161320
Donald, 1992, Prioritizing candidate reproductive/developmental toxicants for evaluation, Reprod Toxicol, 6, 99, 10.1016/0890-6238(92)90027-Q
U. S. General Accounting Office (GAO). Reproductive and developmental toxicants: regulatory actions provide uncertain protection. GAO/PEMD-92–3. Washington: GAO; October 1991.
Vahter, 1994, Species differences in the metabolism of arsenic compounds, Appl Organomet Chem, 8, 175, 10.1002/aoc.590080304
National Research Council. Medical and biologic effects of environmental pollutants: arsenic. Washington: National Academy of Sciences; 1977.
International Programme on Chemical Safety (IPCS), World Health Organization (WHO). Environmental Health Criteria 18: arsenic. Geneva: WHO; 1981.
Wauchope, 1983, Uptake, translocation and phytotoxicity of arsenic in plants, 348
Uthus, 1994, Estimation of safe and adequate daily intake for arsenic, 273
Biddinger, 1984, The importance of trophic transfer in the bioaccumulation of chemical contaminants in aquatic ecosystems, Residue Rev, 91, 103
Phillips, 1990, Arsenic in aquatic organisms, Aquatic Toxicol, 16, 151, 10.1016/0166-445X(90)90036-O
Borum, 1994, Human oral exposure to inorganic arsenic, Environ Geochem Health, 16, 21
Valberg, 1997, Issues in setting health-based cleanup levels for arsenic in soil, Regul Toxicol Pharmacol, 26, 219, 10.1006/rtph.1997.1148
Gunderson, 1995, FDA total diet study, July 1986-April 1991, dietary intakes of pesticides, selected elements, and other chemicals, J AOAC Int, 78, 1353, 10.1093/jaoac/78.4.910
Tay, 1975, Arsenic poisoning from anti-asthmatic herbal preparations, Med J Aust, 2, 424, 10.5694/j.1326-5377.1975.tb105939.x
Kerr, 1986, Arsenic content of homeopathic medicines, J Toxicol Clin Toxicol, 24, 451, 10.3109/15563658608992607
Stecher, 1968
Agency for Toxic Substances and Disease Registry (ATSDR), Centers for Disease Control and Prevention. Minimal risk levels for hazardous substances. Web page http://atsdr1.atsdr.cdc.gov:8080/mrls.html. January 1997.
Agency for Toxic Substances and Disease Registry, Centers for Disease Control and Prevention. Public health statement: arsenic. Web page http://atsdr1.atsdr.cdc.gov:8080/ToxProfiles/phs8802.html. March 1989.
Levine T, Rispin A, Scott CS, Marcus W, Chen C, Gibb H. Special report on ingested inorganic arsenic: skin cancer; nutritional essentiality. EPA/625/3–87/013. Washington: U. S. Environmental Protection Agency; July 1988.
Marafante, 1987, Solubility, retention, and metabolism of intratracheally and orally administered inorganic arsenic compounds in the hamster, Environ Res, 42, 72, 10.1016/S0013-9351(87)80008-7
Mann, 1996, A physiologically based pharmacokinetic model for arsenic exposure. II. Validation and application in humans, Toxicol Appl Pharmacol, 140, 471, 10.1006/taap.1996.0244
Dallaire, 1992, Phosphate transport by capillaries of the blood-brain barrier, J Biol Chem, 267, 22323, 10.1016/S0021-9258(18)41673-0
Gonzalez, 1995, Gastrointestinal absorption of inorganic arsenic (V), Vet Hum Toxicol, 37, 131
Freeman, 1993, Bioavailability of arsenic in soil impacted by smelter activities following oral administration in rabbits, Fundam Appl Toxicol, 21, 83, 10.1006/faat.1993.1075
Freeman, 1995, Bioavailability of arsenic in soil and house dust impacted by smelter activities following oral administration in cynomolgus monkeys, Fundam Appl Toxicol, 28, 215, 10.1006/faat.1995.1162
McKinney, 1992, Metabolism and disposition of inorganic arsenic in laboratory animals and humans, Environ Geochem Health, 14, 43, 10.1007/BF01783627
Tam, 1979, Metabolism of inorganic arsenic (74As) in humans following oral ingestion, Toxicol Appl Pharmacol, 50, 319, 10.1016/0041-008X(79)90157-1
Vahter, 1980, Metabolism of 74As-labeled trivalent and pentavalent inorganic arsenic in mice, Environ Res, 21, 446, 10.1016/0013-9351(80)90049-3
Charbonneau, 1980, Whole-body retention, excretion and metabolism of [74As]arsenic acid in the hamster, Toxicol Lett, 5, 175, 10.1016/0378-4274(80)90056-9
Odanaka, 1980, Biomethylation of inorganic arsenic by the rat and some laboratory animals, Bull Environ Contam Toxicol, 24, 452, 10.1007/BF01608138
Vahter, 1983, Metabolism of arsenic, 171
Vahter, 1981, Biotransformation of trivalent and pentavalent inorganic arsenic in mice and rats, Environ Res, 25, 286, 10.1016/0013-9351(81)90030-X
Hunter, 1942, Radioactive tracer studies on arsenic injected as potassium arsenite, J Pharmacol Exp Therapeutics, 76, 207
Vahter, 1982, Tissue distribution and subcellular binding of arsenic in marmoset monkeys after injection of 74As-arsenite, Arch Toxicol, 51, 65, 10.1007/BF00279322
Vahter, 1995, Lack of methylation of inorganic arsenic in the chimpanzee, Toxicol Appl Pharmacol, 133, 262, 10.1006/taap.1995.1150
Aposhian, 1997, Enzymatic methylation of arsenic species and other new approaches to arsenic toxicity, Ann Rev Pharmacol Toxicol, 37, 397, 10.1146/annurev.pharmtox.37.1.397
Aposhian, 1998, Biodiversity of inorganic arsenite methyltransferases, Toxicol Sci, 42S, 353
Buchet, 1994, Assessment of exposure to inorganic arsenic following ingestion of marine organisms by volunteers, Environ Res, 66, 44, 10.1006/enrs.1994.1043
Ramsey, 1982
Miller, 1976, Transport mechanisms for molecules across placental membranes, 145
Miller, 1983, The placenta, 569
Miller, 1986, Placental transfer and function, 123
Wild, 1981, Endocytic mechanisms of protein transfer across the placenta, Placenta, 1, 165
Eastman, 1931, The arsenic content of the human placenta following arsphenamine therapy, Am J Obstet Gynecol, 21, 60, 10.1016/S0002-9378(31)90842-9
Underhill, 1923, The transmission of arsenic from mother to fetus, J Am Med Assoc, 81, 2009, 10.1001/jama.1923.02650240013004
Snyder, 1938, The placental transmission of neoarsphenamine in relation to the stage of pregnancy, Am J Obstet Gynecol, 36, 579, 10.1016/S0002-9378(38)90526-5
Kagey, 1977, Arsenic levels in maternal-fetal tissue sets, Trace Subst Environ Health, 11, 252
Tabacova, 1994, Placental arsenic and cadmium in relation to lipid peroxides and glutathione levels in maternal-infant pairs from a copper smelter area, Placenta, 15, 873, 10.1016/S0143-4004(05)80188-2
Tabocova, 1994, Complications of pregnancy in relation to maternal lipid peroxides, glutathione, and exposure to metals, Reprod Toxicol, 8, 217, 10.1016/0890-6238(94)90005-1
Dencker, 1983, Disposition of metals in the embryo and fetus, 607
Lindgren, 1984, Embryotoxicity of arsenite and arsenate, Acta Pharmacol Toxicol, 54, 311, 10.1111/j.1600-0773.1984.tb01936.x
Grüneberg, 1943, The development of some external features in mouse embryos, J Hered, 34, 88, 10.1093/oxfordjournals.jhered.a105255
DeSesso, 1997, Comparative embryology, 111
Gerber, 1982, Transfer of antimony and arsenic to the developing organism, Arch Toxicol, 49, 159, 10.1007/BF00332363
Hanlon, 1977, Placental permeability of arsenate ion during early embryogenesis in the hamster, Experientia, 33, 1221, 10.1007/BF01922340
Everett, 1935, Morphological and physiological studies of the placenta in the albino rat, J Exp Zool, 70, 243, 10.1002/jez.1400700206
Boyer, 1953, Chronology of development of the golden hamster, J Morphol, 92, 1, 10.1002/jmor.1050920102
Hamilton, 1972
Hood, 1987, Distribution, metabolism, and fetal uptake of pentavalent arsenic in pregnant mice following oral or i.p. administration, Teratology, 35, 19, 10.1002/tera.1420350104
Hood, 1988, Uptake, distribution, and metabolism of trivalent arsenic in the pregnant mouse, J Toxicol Environ Health, 25, 423, 10.1080/15287398809531221
Buelke-Sam, 1982, Blood flow during pregnancy in the rat. I. Flow patterns to maternal organs, Teratology, 26, 269, 10.1002/tera.1420260309
Buelke-Sam, 1982, Blood flow during pregnancy in the rat. II. Dynamics of and litter variability in uterine flow, Teratology, 26, 279, 10.1002/tera.1420260310
Parisi, 1992, Maternal biologic adaptations to pregnancy, 831
Koren, 1994, Changes in drug disposition in pregnancy and their clinical implications, 3
Goodman, 1941, Drugs used in the chemotherapy of syphilis. I. The pharmacology and clinical toxicology of the antisyphilitic arsenicals: the arsphenamines, mapharsen, and tryparsamide, 946
Hoar, 1981, Comparative development of specific organ systems, 13
Gregus, 1996, Mechanisms of toxicity, 35
Goyer, 1996, Toxic effects of metals, 691
Li, 1992, Effects of sodium arsenite on the cytoskeleton and cellular glutathione levels in cultured cells, Toxicol Appl Pharmacol, 114, 132, 10.1016/0041-008X(92)90105-2
Mottet, 1983, The congenital teratogenicity and perinatal toxicity of metals, 95
Hood, 1983, Toxicology of prenatal exposure to arsenic, 134
Stump, 1998, Evaluation of the teratogenicity of sodium arsenate and arsenic trioxide following single oral or intraperitoneal administration in rats, Teratology, 57, 217
Stump, 1998, An oral developmental toxicity study of arsenic trioxide in rats, Teratology, 57, 216
Stump, 1998, An inhalation developmental toxicity study of arsenic trioxide in rats, Teratology, 57, 216
WIL Research Laboratories, Inc. A teratology study in mice with arsenic acid (75%). Sponsored by Pennwalt Corp. 1988.
Hood RD, Nemec MD, Holson JF, Farr CH. Effects of mid-gestational exposure of mice and rabbits to arsenic acid. Toxicol Sci. 1998;42S:258, full manuscript in preparation.
Henwood SM. Two-generation dietary reproduction study with arsenic acid in mice. Sponsored by Pennwalt Corp., performed by Hazleton Laboratories America, Inc., 1990.
WIL Research Laboratories, Inc. A teratology study in rabbits with arsenic acid (75%). Sponsored by Pennwalt Corp. 1988.
1967
Holmberg, 1969, Interrelationships of selenium, cadmium, and arsenic in mammalian teratogenesis, Arch Environ Health, 18, 873, 10.1080/00039896.1969.10665508
Ferm, 1971, The teratogenic profile of sodium arsenate in the golden hamster, Arch Environ Health, 22, 557, 10.1080/00039896.1971.10665901
Willhite, 1981, Arsenic-induced axial skeletal (dysraphic) disorders, Exp Mol Pathol, 34, 145, 10.1016/0014-4800(81)90071-X
Carpenter, 1987, Developmental analysis of cephalic axial dysraphic disorders in arsenic-treated hamster embryos, Anat Embryol, 176, 345, 10.1007/BF00310189
Hood, 1982, Effects of prenatal arsenite exposure in the hamster, Bull Environ Contam Toxicol, 29, 671, 10.1007/BF01606106
Hood, 1982, Evaluation of arsenic metabolites for prenatal effects in the hamster, Bull Environ Contam Toxicol, 29, 679, 10.1007/BF01606107
Willhite, 1984, Prenatal and developmental toxicology of arsenicals, Adv Exp Med Biol, 177, 205, 10.1007/978-1-4684-4790-3_9
Harris, 1994, Practical guidance for evaluating and interpreting developmental toxicity tests, J Hazardous Materials, 39, 245, 10.1016/0304-3894(94)00052-2
Beaudoin, 1974, Teratogenicity of sodium arsenate in rats, Teratology, 10, 153, 10.1002/tera.1420100211
Mason, 1989, Teratogenicity of combinations of sodium dichromate, sodium arsenate and copper sulphate in the rat, Comp Biochem Physiol, 93C, 407
Hood, 1977, Effects in the mouse and rat of prenatal exposure to arsenic, Environ Health Perspect, 19, 219, 10.1289/ehp.7719219
Umpierre, 1981, Embryolethal and teratogenic effects of sodium arsenite in rats, Teratology, 23, 66A
Kojima, 1974, Studies on developmental pharmacology of arsenic. 2. Effect of arsenite on pregnancy, nutrition and hard tissue, Folia Pharmacol. Japon., 70, 149, 10.1254/fpj.70.149
American Council of Governmental and Industrial Hygienists (ACGIH). Threshold limit values and biologic exposure indices for 1997. Cincinnati: ACGIH; 1997.
Rogers, 1981, The teratogenic potential of cacodylic acid in the rat and mouse, Drug Chem Toxicol, 4, 49, 10.3109/01480548109066371
Nadeenko, 1978, Effect of tungsten, molybdenum, copper and arsenic on the intrauterine development of the foetus, Farmakol Toksikol (Moscow), 41, 620
Hood, 1972, Teratogenic effects of sodium arsenate in mice, Arch Environ Health, 24, 62, 10.1080/00039896.1972.10666051
Hood, 1972, BAL alleviation of arsenate-induced teratogenesis in mice, Teratology, 6, 235, 10.1002/tera.1420060216
Hood, 1978, Prenatal effects of oral vs. intraperitoneal sodium arsenate in mice, J Environ Pathol Toxicol, 1, 857
Morrissey, 1983, Arsenic-induced exencephaly in the mouse and associated lesions occurring during neurulation, Teratology, 28, 399, 10.1002/tera.1420280311
Matsumoto, 1973, Effects of Na-arsenate on the growth and development of the foetal mice, Teratology, 8, 98
Seidenberg, 1986, Validation of an in vivo developmental toxicity screen in the mouse, Teratogen Carcinogen Mutagen, 6, 361, 10.1002/tcm.1770060503
Murakami, 1968, Comparative pathological development of the central nervous system, 136
Hood, 1979, Evaluation of chromated copper arsenate (CCA) for teratogenicity, Teratology, 19, 31A
Hood, 1972, Effects of sodium arsenite on fetal development, Bull Environ Contam Toxicol, 7, 216, 10.1007/BF01684401
Hood, 1984, Evaluation of the effect of BAL (2,3-dimercaptopropanol) on arsenite-induced teratogenesis in mice, Toxicol Appl Pharmacol, 73, 1, 10.1016/0041-008X(84)90045-0
Baxley, 1981, Prenatal toxicity of orally administered sodium arsenite in mice, Bull Environ Contam Toxicol, 26, 749, 10.1007/BF01622166
Schroeder, 1971, Toxic effects of trace elements on the reproduction of mice and rats, Arch Environ Health, 23, 102, 10.1080/00039896.1971.10665963
Nagymajtényi, 1985, Chromosomal aberrations and fetotoxic effects of atmospheric arsenic exposure in mice, J Appl Toxicol, 5, 61, 10.1002/jat.2550050204
Harrison, 1980, Teratogenicity of disodium methanearsonate and sodium dimethylarsinate (sodium cacodylate) in mice, Teratology, 21, 43A
Ma, 1994, Effects of arsenic on the offspring development in mice, Chung-Hua-Yu-Fang-I-Hsueh-Tsa-Chih, 28, 20
Seidenberg, 1987, A summary of the results of 55 chemicals screened for developmental toxicity in mice, Teratogen Carcinogen Mutagen, 7, 17, 10.1002/tcm.1770070105
James, 1966, Effects of sublethal doses of certain minerals on pregnant ewes and fetal development, Am J Vet Res, 27, 132
Wilson, 1973
Beckman, 1992, Basic principles of teratology, 293
DeSesso, 1996, Principles underlying developmental toxicity, 37
Wilson, 1965, Embryological considerations in teratology, 251
Moore, 1993
Sadler, 1995
Larsen, 1997
Mirkes, 1992, A comparison of sodium arsenite- and hyperthermia-induced stress responses and abnormal development in cultured postimplantation rat embryos, Teratology, 46, 251, 10.1002/tera.1420460308
Tabocova, 1996, Developmental toxicity of inorganic arsenic in whole embryo culture, Toxicol Appl Pharmacol, 138, 298, 10.1006/taap.1996.0128
Chaineau, 1990, Embryotoxic effects of sodium arsenite and sodium arsenate on mouse embryos in culture, Teratology, 41, 105, 10.1002/tera.1420410111
Müller, 1986, Toxicity of sodium arsenite in mouse embryos in vitro and its influence on radiation risk, Arch Toxicol, 59, 172, 10.1007/BF00316328
Sadler, 1988, The role of pharmacokinetics in determining the response of rodent embryos to teratogens in whole-embryo culture, Toxicol in Vitro, 2, 175, 10.1016/0887-2333(88)90005-7
Schwetz, 1993, In vitro approaches in developmental toxicology, Reprod Toxicol, 7S, 125, 10.1016/0890-6238(93)90078-L
Beaudoin, 1981, An in vivo/in vitro evaluation of teratogenic action, Teratology, 23, 57, 10.1002/tera.1420230108
Fisher, 1982, Cultured rat embryo accumulation of DNA, RNA, and protein following maternal administration of sodium arsenate, Environ Res, 28, 1, 10.1016/0013-9351(82)90148-7
Ancel, 1941, Sur l’arrêt de développement du bourgeon caudal obtenu expérimentalement chez l’embryon de poulet, Arch Physique Biol, 15, 27
Ancel P. Recherche expérimentale sur le spina bifida. Arch Anat microsc Morph Exp. 1946–1947;36:45–68.
Ridgway, 1952, The effects of metals on the chick embryo, Ann NY Acad Sci, 55, 203, 10.1111/j.1749-6632.1952.tb26536.x
Birge, 1976, Toxicity of metals to chick embyros, Bull Environ Contam Health, 16, 319, 10.1007/BF01685895
Peterková, 1976, Effect of trivalent and pentavalent arsenic on early developmental stages of the chick embryo, Folia Morphol, 24, 5
Gilani, 1990, Teratogenicity of metals to chick embryos, J Toxicol Environ Health, 30, 23, 10.1080/15287399009531407
Puzanová, 1976, Mechanism of the development of malformations in chick embryos after administration of arsenic, Sbornı́k Lékarský, 78, 57
Albert, 1981
Bolliger, 1992, Multiple organ failure with the adult respiratory distress syndrome in homicidal arsenic poisoning, Respiration, 59, 57, 10.1159/000196026
Lugo, 1969, Acute maternal arsenic intoxication with neonatal death, Am J Dis Child, 117, 328
Daya, 1989, Arsenic ingestion in pregnancy, Vet Hum Toxicol, 31, 347
Kantor, 1948, Arsenical encephalopathy in pregnancy with recovery, Am J Obstet Gynecol, 56, 370, 10.1016/0002-9378(48)90282-8
Ihrig MM. Effect of chronic inhalation of inorganic arsenic on the risk of stillbirth in a community surrounding an agriculture chemical production facility: a hospital-based study. Thesis, Texas A&M University, 1997.
Ihrig MM, Shalat SL, Baynes C. Risk of stillbirth in a community surrounding an arsenical based agriculture chemical production facility. Am J Epidemiol. 1997;145: abstract 77. Published in full after this submission as Ihrig MM, Shalat SL, Baynes C. A hospital-based case-control study of stillbirths and environmental exposure to arsenic using an atmospheric dispersion model linked to a geographical information system. Epidemiol. 1998;9:290–4.
Zierler, 1988, Chemical quality of maternal drinking water and congenital heart disease, Int J Epidemiol, 17, 589, 10.1093/ije/17.3.589
Aschengrau, 1989, Quality of community drinking water and the occurrence of spontaneous abortion, Arch Environ Health, 44, 283, 10.1080/00039896.1989.9935895
Office of Ground Water & Drinking Water, U. S. Environmental Protection Agency. National primary drinking water standards. Web page http://www.epa.gov/OGWDW/wot/appa.html. February. 1998.
Börzsönyi, 1992, Epidemiological studies on human subjects exposed to arsenic in drinking water in southeast Hungary [letter], Arch Toxicol, 66, 77, 10.1007/BF02307274
Nordström, 1978, Occupational and environmental risks in and around a smelter in northern Sweden. I. Variations in birth weight, Hereditas, 88, 43, 10.1111/j.1601-5223.1978.tb01600.x
Nordström, 1978, Occupational and environmental risks in and around a smelter in northern Sweden. III. Frequencies of spontaneous abortion, Hereditas, 88, 51, 10.1111/j.1601-5223.1978.tb01602.x
Nordström, 1979, Occupational and environmental risks in and around a smelter in northern Sweden. V. Spontaneous abortion among female employees and decreased birth weight in their offspring, Hereditas, 90, 291, 10.1111/j.1601-5223.1979.tb01316.x
Nordström, 1979, Occupational and environmental risks in and around a smelter in northern Sweden. VI. Congenital malformations, Hereditas, 90, 297, 10.1111/j.1601-5223.1979.tb01317.x
Beckman, 1982, Occupational and environmental risks in and around a smelter in northern Sweden. IX. Fetal mortality among wives of smelter workers, Hereditas, 97, 1, 10.1111/j.1601-5223.1982.tb00703.x
Texas Department of Health. An investigation of a cluster of neural tube defects in Cameron County, Texas. July 1992.
Roscoe, 1862, On the alleged practice of arsenic-eating in Styria, Mem Lit Phil Soc Manchester, 3xs.,i, 208
Maclagen, 1864, On the arsenic-eaters of Styria, Edinburgh Med J, 10, 200
Maclagen, 1875, Arsenic-eaters of Styria, Edinburgh Med J, 21, 526
Reynolds, 1901, An account of the epidemic outbreak of arsenical poisoning occurring in beer-drinkers in the north of England and the midland counties in 1900, Lancet, 1, 166, 10.1016/S0140-6736(01)81229-0
Mizuta, 1956, An outbreak of acute arsenic poisoning caused by arsenic contaminated soy-sauce (shoyu), Bull Yamaguchi Med School, 4, 131
Tseng, 1968, Prevalence of skin cancer in an endemic area of chronic arsenicism in Taiwan, J National Cancer Inst, 40, 453
Ch’i, 1968, A controlled retrospective study of Blackfoot disease, an endemic peripheral gangrene disease in Taiwan, Am J Epidemiol, 88, 7, 10.1093/oxfordjournals.aje.a120869
Zaldı́var, 1974, Arsenic contamination of drinking water and foodstuffs causing endemic chronic poisoning, Beitr Pathol, 151, 384, 10.1016/S0005-8165(74)80047-8
Vahter, 1995, A unique metabolism of inorganic arsenic in native Andean women, Eur J Pharmacol (Environ Toxicol Pharmacol Section), 293, 455, 10.1016/0926-6917(95)90066-7
Birmingham, 1965, An outbreak of arsenical dermatoses in a mining community, Arch Dermatol, 91, 457, 10.1001/archderm.1965.01600110043010
Nelson, 1973, Mortality among orchard workers exposed to lead arsenate spray, J Chron Dis, 26, 105, 10.1016/0021-9681(73)90009-X
Milham, 1974, Human arsenic exposure in relation to a copper smelter, Environ Res, 7, 176, 10.1016/0013-9351(74)90148-0
U. S. Environmental Protection Agency. Guidelines for developmental toxicity risk assessment. Federal Register. 1991;56:63798–826.
Nelson, 1978, Statistical analysis of teratologic data, J Environ Pathol Toxicol, 2, 187
Ferm, 1985, Constant rate exposure of pregnant hamsters to arsenate during early gestation, Environ Res, 37, 425, 10.1016/0013-9351(85)90124-0
Hanlon, 1986, Concentration and chemical status of arsenic in the blood of pregnant hamsters during critical embryogenesis. 1. Subchronic exposure to arsenate utilizing constant rate administration, Environ Res, 40, 372, 10.1016/S0013-9351(86)80112-8
Hanlon, 1986, Concentration and chemical status of arsenic in the blood of pregnant hamsters during critical embryogenesis. 2. Acute exposure, Environ Res, 40, 380, 10.1016/S0013-9351(86)80113-X
Hanlon, 1987, The concentration and chemical status of arsenic in the early placentas of arsenate-dosed hamsters, Environ Res, 42, 546, 10.1016/S0013-9351(87)80221-9
Davis, 1992, Bioavailability of arsenic and lead in soils from the Butte, Montana district, Environ Sci Technol, 26, 461, 10.1021/es00027a002
1965
Warkany, 1971
Lemire, 1978
1991
Padmanabhan, 1991, Is exencephaly the forerunner of anencephaly?, Acta Anat (Basel), 141, 182, 10.1159/000147120
Wise, 1997, Terminology of developmental abnormalities in common laboratory mammals (version I), Teratology, 55, 249, 10.1002/(SICI)1096-9926(199704)55:4<249::AID-TERA5>3.0.CO;2-W
1977